FOCIS invites member societies to contribute to Immunology Update, the quarterly FOCIS e-Newsletter, by submitting a short article or announcement via the online submission form.

Submission form click HERE

What can you submit?

• News items – New scientific advancements, publications, or discoveries to share with nearly 1,000 FOCIS members

• Conference or consortium announcements – Promote upcoming conferences or consortiums, increase registrations, or link directly to virtual content

• Brief articles – Short overviews of larger articles hosted on your website, including a “read more” link

• Award recognitions – Highlight achievements of members, students, staff, associates, technicians, and others

• Member resources – Share resources relevant to the FOCIS community

Submission deadlines

• February issue: February 6, 2026

• April issue: April 3, 2026

Guidelines

• Photos, images, or graphics are encouraged (may be resized for placement)

• Please include links to additional information
  
  Word count:

• News items, announcements, award recognitions: 50–250 words
• Articles: up to 500 words

Lymph&Co is happy to announce two calls for 2026.

1. Call for research proposals 2026

The Lymph&Co Foundation intends to fund one research project in 2026.

There will be a two-stage submission procedure for applications: pre-proposals and full proposals. The call opens on February 2. The deadline for submitting the pre-proposals is 8April 2026. The Scientific Board of Lymph&Co will carry out a scientific evaluation according to specific evaluation criteria. Based on this evaluation, selected applicants will be invited to submit a full proposal (deadline for full proposals: 6 August 2026).

More information:

The fellowship supports the opportunity for a talented young researcher (below the age of 40 years and within 6 years of obtaining his/her PhD) to visit an internationally renowned research group in the field of lymphoma. The fellowship is intended to further the career of young researchers in basic, translational or clinical research residing in the Netherlands. The application should be supported by a recommendation letter from the head of the department the applicant is currently working. In addition, a letter of acceptance by the head of the host department is required and hosting teams are invited to submit their joint nomination together using the Paul Fentener van Vlissingen Lymphoma Fellowship application form available on the Lymph&Co website.

Deadline: 6 August 2026.

About the Lymph&Co Foundation

Lymph&Co is funding innovative scientific translational research to treatment and prevention of lymphoma by outstanding researchers worldwide. In addition, we aim to generate attention and publicity for all types of lymphoma. Visit our website for more information about Lymph&Co.